SEC Form D · filed December 22, 2015
Navitor Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Marian Nakada · Cambridge, MADirectorRick P. Lundberg · Cambridge, MAExecAlan P. Crane · Cambridge, MADirectorGeorge P. Vlasuk · Cambridge, MAExec · DirectorVinzenz P. Ploerer · Cambridge, MADirectorDavid P. Madden · Cambridge, MADirectorCapital Management, Inc. Conrad · Islandia, NYDirectorDavid Icikson · New York, NYExecJonathan Neiss · NEW YORK, NYDirectorDonald E. Conrad · Islandia, NYDirectorSeth Lax · NEW YORK, NYExec · DirectorAaron Katz · New York, NYDirectorJean-Francois Formela · Broomfield, CODirectorBrian Gallagher · Dublin, IrelandDirectorPaul Friedman · New York, NYDirectorBarry P. Burgdorf · Cambridge, MADirectorBrenda Smith · Conshohocken, PAExecPawel Gierynski · Warsaw, R9DirectorStephen Richmond · Warsaw, R9DirectorGeorge Swirski · Warsaw, R9DirectorNeil Milne · Warsaw, R9Exec · DirectorWilliam Manby · Akron, OHDirectorJean-Francois Formela · Cambridge, MADirectorBrian Gallagher · Simsbury, CTDirectorPaul Friedman · San Francisco, CADirectorBarry P. Burgdorf · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗